Study #2023-0899
High dose Ruxolitinib and Allogeneic stem cell transplantation in myelofibrosis patients with splenomegaly.
MD Anderson Study Status
Enrolling
Treatment Agent
Ruxolitinib, Levetiracetam, Eltrombopag, Busulfan, Romiplostim, Fludarabine phosphate, Cyclophosphamide, Mesna, Tacrolimus
Description
To learn if giving ruxolitinib and busulfan before a stem cell transplant can help to reduce spleen size and help the transplant to succeed.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Splenomegaly, Myelofibrosis
Study phase:
Phase II
Physician name:
Uday Popat
Department:
Stem Cell Transplantation
For general questions about clinical trials:
1-877-327-0346
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.